Browse by Current Cardiff authors
Number of items: 6.
Freeman, S., Hills, Robert Kerrin, Virgo, P., Couzens, Stephen, Lowdell, M. W., McNamara, C. J., White, Paul Charles and Burnett, Alan Kenneth
2010.
Detection of immunophenotypic residual disease after induction therapy is an independent prognostic factor for duration of remission in older AML patients treated intensively [Abstract].
Blood
116
(21)
, pp. 1118-1119.
|
|
Tonks, Alex, Tonks, Amanda Jayne, Pearn, Lorna, Pearce, Laurence, Hoy, Terence George, Couzens, Stephen, Fisher, Janet, Burnett, Alan Kenneth and Darley, Richard Lawrence
2004.
Expression of AML1-ETO in human myelomonocytic cells selectively inhibits granulocytic differentiation and promotes their self-renewal.
Leukemia
18
(7)
, pp. 1238-1245.
10.1038/sj.leu.2403396
|
|
Tonks, Alex, Tonks, Amanda Jayne, Pearn, Lorna, Pearce, L., Hoy, T., Couzens, Stephen, Fisher, J., Burnett, Alan Kenneth and Darley, Richard Lawrence
2004.
Expression of AML1-ETO in human myelomonocytic cells selectively inhibits granulocytic differentiation and promotes their self-renewal.
Leukemia
18
(7)
, pp. 1238-1245.
10.1038/sj.leu.2403396
|
|
Lim, Seah H., Culligan, Dominic, Couzens, Stephen, Fisher, Janet, John, Susan, Pollard, Peter, Burnett, Alan Kenneth and Whittaker, Jack
1996.
Molecular evidence for a common leukaemic progenitor in acute mixed lymphoid and myeloid leukaemia.
British Journal of Haematology
92
(1)
, pp. 131-133.
10.1046/j.1365-2141.1996.281821.x
|
|
Poynton, Christopher H., Fegan, Christopher Daniel, Al-Sabah, Ali I., Couzens, Stephen, John, S., Hoy, Terence George, White, D. and Burnett, Alan Kenneth
1994.
Aberrant durface phenotype in MDS confers a poor-prognosis with more rapid development of AML [Abstract].
Blood
84
(10)
, A316.
|
|
This list was generated on Sat Jan 23 04:02:31 2021 GMT.